Cambridge, MA · Founded 2019 · Privately Held (backing)
Developer of a biomedical neuromodulation therapy designed to sustain pain relief and support mobility. Brixton Biosciences is based in Cambridge, MA and was founded in 2019. It has raised $41 million.
Last price · $/share
—
Implied valuation
—
Total raised
$41.0M
Last round
—
Team — not yet on record
No current team members for Brixton Biosciences are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Brixton Biosciences with a free account
·The complete investor list: 11 names
·Watch Brixton Biosciences: the Monday email on marks, rounds and moves
